Cogent Biosciences
COGT
COGT
36 hedge funds and large institutions have $17.8M invested in Cogent Biosciences in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
47% less capital invested
Capital invested by funds: $33.7M → $17.8M (-$15.9M)
Holders
36
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$170K | |
| 2 | +$107K | |
| 3 | +$99.8K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$65K |
| 5 |
Goldman Sachs
New York
|
+$64.7K |
Top Sellers
| 1 | -$447K | |
| 2 | -$237K | |
| 3 | -$176K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$133K |
| 5 |
Jane Street
New York
|
-$132K |